Berman Capital Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Berman Capital Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-65	Closed	-$3K	–	1918
2020 Q3	$3K	Sell	65 -82	-56%	-$3.39K	﹤0.01%	1241
2020 Q2	$4K	Buy	+147	New	+$4.68K	﹤0.01%	1098
2019 Q3	–	Sell	-54	Closed	–	–	1651
2019 Q2	$0	Buy	+54	New	+$717	﹤0.01%	1645

Berman Capital Advisors's MNTA Position: Q4 2020 in Review

Berman Capital Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 65 shares — an estimated $3K sold.

Berman Capital Advisors first reported a position in MNTA in Q2 2019 and held it in 3 quarters. The position peaked at $4K in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Berman Capital Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Berman Capital Advisors sold 65 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $3K.
Berman Capital Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2019 and held it in 3 quarters.
Berman Capital Advisors's Momenta Pharmaceuticals, Inc. position peaked at $4K in Q2 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Berman Capital Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.